Celldex Therapeutics | CLDX - Текущие обязательства





Текущие обязательства Изменить Дата
AbbVie USD 43.1B 1.46B 2026-09
Agenus USD 231.82M 17.42M 2026-06
Amgen USD 23.23B 2.27B 2026-09
Bristol-Myers Squibb USD 18.75B 94M 2026-09
Celldex Therapeutics USD 60.52M 808K 2026-09
Glaxosmithkline GBP 20.72B 1.71B 2026-09
Nektar Therapeutics USD 57.71M 4.17M 2026-03
Northwest Biotherapeutics USD 82.97M 4.93M 2026-03
Pfizer USD 31.73B 920M 2026-09
Rigel Pharmaceuticals USD 94.4M 7.76M 2025-09
Roche Holding CHF 28.85B 846M 2026-06